WHO we are
Mission and Strategy 
The LGRC (Lung Genomics Research Consortium) is a group of top scientists from five U.S. institutions, whose mission is to transform our understanding of chronic lung diseases such as chronic obstructive pulmonary disease (COPD) interstitial lung disease (ILD)… Read More
Project Background
Lung disease is a significant worldwide health problem. In the United States alone, chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death, and interstitial lung disease, or ILD, kills approximately 400,000 Americans every year… Read More
Funding the LGRC
The LGRC was established through an $11 million grant from the National Heart, Lung, and Blood Institute (NHLBI), which is funding the first two years of the project… Read More
Our Research Team
This LGRC team is comprised of researchers from five preeminent research centers: National Jewish Health, the University of Colorado School of Medicine, the University of Pittsburgh School of Medicine, the Dana-Farber Cancer Institute, and the Boston University School of Medicine… Read More
Our Partners
Researchers at the LGRC are using advanced technologies from several companies to create a state-of-the-art genetic and molecular library, or information warehouse, that scientists everywhere can access and use to characterize and redefine chronic lung disease... Read More
